Issues at Novo Nordisk lead to shortage of fast-acting diabetes drug
The Danish Medicines Agency has reported that it is currently difficult to find diabetes drug Novorapid in Denmark.
by christian bundgaard, translated by catherine brett
There is a current shortage of Novo Nordisk’s fast-acting diabetes drug Novorapid 100 E/ml in Denmark, the Danish Medicines Agency has announced.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA approves Eli Lilly diabetes drug
For subscribers
Novo Nordisk appoints new general manager for Turkiye
For subscribers
.jpg&w=384&q=75)
